Uchida, Naoya
National Institutes of Health · National Institute of Diabetes and Digestive and Kidney Diseases · National Heart, Lung, and Blood Institute · Institute of Medical Science, The University of Tokyo
3 papers on CoChatORCID 0000-0001-6322-8991
Most cited papers
- Verified
Genome editing of HBG1 and HBG2 to induce fetal hemoglobin
Métais, J.-Y., Doerfler, P. A., Mayuranathan, T., Bauer, D. E., Fowler, S. C., Hsieh, M. M., Katta, V., Keriwala, S., Lazzarotto, C. R., Luk, K., et al. (2019) · Blood Advances
Hemoglobinopathies and Related DisordersCRISPR and Genetic Engineering
Cited by 177
- Verified
Myelodysplastic syndrome unrelated to lentiviral vector in a patient treated with gene therapy for sickle cell disease
Hsieh, M. M., Bonner, M., Pierciey, F. J., Uchida, N., Rottman, J., Demopoulos, L., Schmidt, M., Kanter, J., Walters, M. C., Thompson, A. A., et al. (2020) · Blood Advances
Virus-based gene therapy researchHemoglobinopathies and Related Disorders
Cited by 152
- Verified
Cas9 protein delivery non-integrating lentiviral vectors for gene correction in sickle cell disease
Uchida, N., Drysdale, C. M., Nassehi, T., Gamer, J., Yapundich, M., DiNicola, J., Shibata, Y., Hinds, M., Gudmundsdottir, B., Haro-Mora, J. J., et al. (2021) · Molecular Therapy - Methods & Clinical Development
Virus-based gene therapy researchCRISPR and Genetic Engineering
Cited by 55
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free